Vontobel Holding
LEXX icon

Vontobel Holding’s Lexaria Bioscience LEXX Stock Holding History

Vontobel Holding’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.51K Sell
1,013
-520
-34% -$5.64K ﹤0.01% 1469
2026
Q1 		$17.9K Buy
+1,533
New +$16.7K ﹤0.01% 1185

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vontobel Holding's LEXX Position: Q2 2026 in Review

Vontobel Holding reduced its Lexaria Bioscience (LEXX) stake by 34% in Q2 2026, selling an estimated $5.64K and leaving 1,013 shares worth $8.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

Vontobel Holding first reported a position in LEXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $17.9K in Q1 2026. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

  • Vontobel Holding held 1,013 shares of Lexaria Bioscience worth $8.51K as of Q2 2026.
  • Vontobel Holding sold 520 Lexaria Bioscience shares in Q2 2026, an estimated $5.64K.
  • Lexaria Bioscience made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1469 holding.
  • Vontobel Holding first reported a position in Lexaria Bioscience in Q1 2026 and has held it in 2 quarters since.
  • Vontobel Holding's Lexaria Bioscience position peaked at $17.9K in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.